Albireo Pharma Inc PER
¿Qué es el PER de Albireo Pharma Inc?
El PER de Albireo Pharma Inc es 0.00
¿Cuál es la definición de PER?
La relación precio/ganancias es la relación entre el precio de las acciones de una compañía y las ganancias por acción de la compañía calculadas en los últimos doce meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
PER de compañías en Sector Health Care en NASDAQ en comparadas con Albireo Pharma Inc
¿Qué hace Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Empresas con per similar a Albireo Pharma Inc
- Richland Resources International tiene PER de N/A
- Safeplus International tiene PER de N/A
- China Yanyuan Yuhui Natl Ed Grp tiene PER de N/A
- Acusphere tiene PER de N/A
- American Oriental Bioengineering tiene PER de N/A
- Gourmet Provisions International tiene PER de N/A
- Albireo Pharma Inc tiene PER de 0.00
- SEL Manufacturing tiene PER de 0.00
- China Zhong Qi Hldgs tiene PER de 0.00
- MedSmart tiene PER de 0.00
- Panbela Therapeutics tiene PER de 0.00
- Epic tiene PER de 0.00
- 2574 tiene PER de 0.00